Edgardo Rivera

7.1k total citations · 1 hit paper
63 papers, 4.5k citations indexed

About

Edgardo Rivera is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, Edgardo Rivera has authored 63 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 15 papers in Cancer Research and 11 papers in Dermatology. Recurrent topics in Edgardo Rivera's work include Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (16 papers) and Breast Cancer Treatment Studies (14 papers). Edgardo Rivera is often cited by papers focused on Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (16 papers) and Breast Cancer Treatment Studies (14 papers). Edgardo Rivera collaborates with scholars based in United States, United Kingdom and Italy. Edgardo Rivera's co-authors include Gabriel N. Hortobágyi, Vicente Valero, Richard L. Theriault, Nuhad K. Ibrahim, Daniel J. Booser, Henry Gómez, Bita Esmaeli, Charles S. Cleeland, Lajos Pusztai and Charles D. Collard and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Edgardo Rivera

63 papers receiving 4.3k citations

Hit Papers

Phase I and pharmacokinetic study of ABI-007, a Cremophor... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
    2002 504 citations Nuhad K. Ibrahim, Richard L. Theriault et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgardo Rivera United States 36 2.7k 983 914 850 491 63 4.5k
Mourad Tighiouart United States 38 1.7k 0.6× 700 0.7× 1.6k 1.8× 930 1.1× 230 0.5× 152 5.0k
Katherine H. R. Tkaczuk United States 21 1.8k 0.7× 968 1.0× 436 0.5× 387 0.5× 288 0.6× 47 2.8k
Keun Seok Lee South Korea 39 2.8k 1.0× 1.3k 1.3× 736 0.8× 1.1k 1.3× 491 1.0× 175 4.9k
Klaas Hoekman Netherlands 41 2.4k 0.9× 983 1.0× 1.9k 2.1× 999 1.2× 136 0.3× 102 5.2k
Stefan Glück United States 40 3.2k 1.2× 1.0k 1.0× 1.2k 1.3× 1.1k 1.3× 132 0.3× 199 5.6k
Guido Bocci Italy 42 2.6k 0.9× 1.2k 1.3× 2.4k 2.6× 1.0k 1.2× 221 0.5× 206 5.8k
Alberto J. Montero United States 36 2.8k 1.0× 816 0.8× 1.3k 1.4× 1.0k 1.2× 203 0.4× 186 5.3k
D L Trump United States 33 2.0k 0.7× 411 0.4× 1.1k 1.2× 1.6k 1.9× 375 0.8× 76 4.8k
Epie Boven Netherlands 45 3.3k 1.2× 1.1k 1.1× 3.0k 3.2× 2.0k 2.4× 213 0.4× 190 7.5k
J Cassidy United Kingdom 33 1.7k 0.6× 340 0.3× 1.2k 1.3× 594 0.7× 549 1.1× 79 4.5k

Countries citing papers authored by Edgardo Rivera

Since Specialization
Citations

This map shows the geographic impact of Edgardo Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgardo Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgardo Rivera more than expected).

Fields of papers citing papers by Edgardo Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgardo Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgardo Rivera. The network helps show where Edgardo Rivera may publish in the future.

Co-authorship network of co-authors of Edgardo Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Edgardo Rivera. A scholar is included among the top collaborators of Edgardo Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgardo Rivera. Edgardo Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivera, Edgardo, Jenny C. Chang, Semiglazov Vf, et al.. (2013). Eniluracil Plus 5-Fluorouracil and Leucovorin: Treatment for Metastatic Breast Cancer Patients in Whom Capecitabine Treatment Rapidly Failed. Clinical Breast Cancer. 14(1). 26–30. 7 indexed citations
2.
Nguyen, Bichlien, P. Cusumano, Kenneth Deck, et al.. (2012). Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients. Annals of Surgical Oncology. 19(10). 3257–3263. 30 indexed citations
3.
Rivera, Edgardo & Henry Gómez. (2010). Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Research. 12(S2). S2–S2. 164 indexed citations
4.
Rivera, Edgardo, Jaime Mejia, Banu Arun, et al.. (2008). Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer. Cancer. 112(7). 1455–1461. 81 indexed citations
5.
Rivera, Edgardo, Christina Meyers, Morris D. Groves, et al.. (2006). Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 107(6). 1348–1354. 119 indexed citations
6.
Basen‐Engquist, Karen, Cindy L. Carmack Taylor, Carol Rosenblum, et al.. (2006). Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Education and Counseling. 64(1-3). 225–234. 140 indexed citations
7.
8.
Alberts, David S., Franco M. Muggia, James Carmichael, et al.. (2004). Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology. 31(6 Suppl 13). 53–90. 114 indexed citations
9.
10.
Rivera, Edgardo, et al.. (2003). Targeted filgrastim support in patients with early‐stage breast carcinoma. Cancer. 98(2). 222–228. 20 indexed citations
11.
Pusztai, Lajos, Tito R. Mendoza, James M. Reuben, et al.. (2003). Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 25(3). 94–102. 253 indexed citations
12.
Escalante, Carmen P., et al.. (2003). Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Supportive Care in Cancer. -1(1). 1–1. 43 indexed citations
13.
Rivera, Edgardo, Frankie A. Holmes, Aman U. Buzdar, et al.. (2002). Fluorouracil, Doxorubicin, and Cyclophosphamide Followed by Tamoxifen as Adjuvant Treatment for Patients with Stage IV Breast Cancer with No Evidence of Disease. The Breast Journal. 8(1). 2–9. 43 indexed citations
14.
Escalante, Carmen P., Beth A. Johnson, M. Härle, et al.. (2001). A fatigue clinic in a comprehensive cancer center. Cancer. 92(S6). 1708–1713. 22 indexed citations
15.
Cristofanilli, Massimo, Aman U. Buzdar, Nour Sneige, et al.. (2001). Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer. 92(7). 1775–1782. 54 indexed citations
16.
Rivera, Edgardo, Frankie A. Holmes, Vicente Valero, et al.. (2000). Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy. Cancer. 89(11). 2195–2201. 15 indexed citations
17.
Rivera, Edgardo & Jaffer A. Ajani. (1998). Doxorubicin, Streptozocin, and 5-Fluorouracil Chemotherapy for Patients with Metastatic Islet-Cell Carcinoma. American Journal of Clinical Oncology. 21(1). 36–38. 71 indexed citations
18.
Rivera, Edgardo, Vicente Valero, & Gabriel N. Hortobágyi. (1996). Breast Cancer in Identical Twins with Different Clinical Course. The Breast Journal. 2(6). 394–399. 1 indexed citations
19.
Rivera, Edgardo, Vicente Valero, & Gabriel N. Hortobágyi. (1996). Breast Cancer in Identical Twins with Different Clinical Course. The Breast Journal. 2(6). 400–402. 1 indexed citations
20.
Fossella, Frank V., Edgardo Rivera, & Jack A. Roth. (1996). Preoperative chemotherapy for stage Ilia non-small cell lung cancer. Current Opinion in Oncology. 8(2). 106–111. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mourad Tighiouart Breakdown of academic impact, for papers by Katherine H. R. Tkaczuk Breakdown of academic impact, for papers by Keun Seok Lee Breakdown of academic impact, for papers by Klaas Hoekman Breakdown of academic impact, for papers by Stefan Glück Breakdown of academic impact, for papers by Guido Bocci Breakdown of academic impact, for papers by Alberto J. Montero Breakdown of academic impact, for papers by D L Trump Breakdown of academic impact, for papers by Epie Boven Breakdown of academic impact, for papers by J Cassidy
Rankless by CCL
2026